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Stephen S. Gottlieb, Michelle Cines, Vivek Nag, Michael l. Fisher. University of
Maryland School of Medicine, Baltimore, MD
The efficacy of digoxin (dig) in heart failure patients with normal sinus rhythm
is related to a fall in systemic vascular resistance (SVR) caused directly &
indirectly by decreased neurohormonal activation. To determine if prior ACE
inhibition (ACE-I) limits the hemodynamic effects of IV dig, we compared
the response of 26 pts receiving ACE-I to 7 pts not exposed to ACE-I. Mean
daily ACE-I doses were enalapril 21 mg or captopril 94 mg. Mean arterial,
pulmonary capillary wedge & right atrial pressures (MAP. PCW &RAp' mmHgl,
systemic vascular resistance (SVR, d-s-cl. cardiac index (CI. IImin/M2) heart
rate (HR, min-1) and ejection fraction (EF, %) were assessed at baseline. Pts
were severely ill, with no differences between groups:
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APCW ACI AMAP AHR ARAP ASVR
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ACE-I -3" +0.4" +8" -4" -4" -186
No ACE-I _8"·t +0.5" +5 -9" -6" -335
Pts were then given two 0.5 mg doses of dig, 2 hrs apart. Change (A) in
hemodynamic parameters from before drug administration to 2 hours after
the second dose of dig are shown for all pts (ALL) and for pts receiving and
not receiving ACE-I, with * = p < 0.05 v. baseline. ACE-I and No ACE-I pts
were compared, with differences between groups shown as t = P < 0.05 v.
ACE-I:
Variations in care following PTCA may greatly affect the cost per hospital-
ization. To assess for common practices that might lead to increased costs,
76 institutions participating in the IMPACT II clinical trial were surveyed. The
survey revealed common institutional practices that may lead to increased
care costs for routine angioplasty patients. Practice patterns identified (n =
70) were:
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Key Factors
Transfuse at HCT of :::27% (ACP guideline :::22%)
NurselPatient Ratio of 2:1
Patients Admitted to ICU Post PTCA
Always Use Arterial and Venous Sheaths
leave Sheaths In Place for 12-18 Hours
Leave Sheaths in Place for Greater than 18 Hours
lab Work Required Within 24 Hours Prior to Procedure
Use of ST Segment Monitors
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In the current era of limited health care resources and health care reform,
it is critical to reassess traditional practices that may not be sensitive to cost
containment. Health care professionals need to collaborate to identify a stan-
dard of care for these patients that promotes safety and favorable outcomes,
yet are also cost-effective.
"p < 005 v. baseline, t p < 0.05 v. ACE-I
Dig caused a marked hemodynamic response in all pts. However, PCW,
RAP. SVR, and HR decreased less in ACE-I pts. Similarly, MAP tended to in-
crease more in pts receiving ACE-I.
Conclusion: IV dig exerts a marked hemodynamic response in severely
ill CHF pts receiving ACE-I. However, ACE-I limits the extent of vasodilation
caused by acute digoxin administration. 1 1032-1161 High Marginal Costs Associated with Routine
Placement of Coronary Stents
Beneficial Effects of Ramipril in a Model of
Isoproterenol-induced Heart Failure In the Rat
Daniela G. Grimm, Dietmar Elsner, Gunter Bruckschlegel, Christl Peter,
Stephan Holmer, Gunter A Riegger, Eckhard P. Kromer. Klink fiir Innere Medizin II,
University of Regensburg, Germany
To establish an experimental model of chronic heart failure, we assessed the
morphologic, hemodynamic and neurohumoral effects of a single large dose
for isoproterenol (ISO: 150 mglkg BW s.c.). Two weeks after ISO-application
45 150- and 30 control-rats were examined. In addition, we investigated
the effects of chronic treatment with ramipril IRAM: 10 mg/KG/d, n = 20).
Echocardiography of 150- and control-rats was performed in anesthetized
rats to measure left ventricular (LV) mass and LV-enddiastolic dimension. An
increase of LV-mass (LV diastolic posterior wall thickness: 2.8 ± 0.2 vs. 1.9
± 0.3 mm, LV systolic posterior wall thickness: 4.3 ± 0.4 vs. 3.6 ± 0.3 mm; p
< 0.01) and LV enddiastolic dimension (6.9 ± 0.6 vs. 4.9 ± 0.3 mm p < 0.01)
was displayed. RAM-treated animals showed a highly significant decrease of
LV mass and LV-enddiastolic dimension (p < 0.001). Heart rate was increased
in the ISO-group (p < 0.005) compared to RAM- and control-rats (p < 0.005).
Central venous pressure was significantly increased in the ISO-group (5.8 ±
2.3; vs 2.3 ± 0.6 mmHG; p < 0.01) and decreased to normal ranges in RAM-
rats. Mean arterial pressure was decreased in ISO- (121.3 ± 14.8 mmHg)
and RAM-rats, (95 ± 3 mmHG) vs controls (132.4 ± 19.5 mmHG)(p < 0.05).
Mean renal blood flow between ISO-treated and control group was not sig-
nificantly different, in contrast the mean blood flow in the abdominal aorta
was decreased in the ISO-group Ip < 0.051. Cardiac ACE-activity (p < 0.01),
circulating atrial natriuretic peptide, renin- and aldosterone-levels were sig-
nificantly higher in the ISO-treated group as compared tothe control group (p
< 0.05). ISO-treated hearts displayed morphological alterations such as my-
ocyte necrosis, cellular reaction and fibrosis. RAM-treated hearts revealed
the same infarct-like lesions but at a lower grade.
In summary, a highly reproducible model of chronic heart failure was estab-
lished. Hemodynamic measurements displayed a typical characteristic for
advanced heart failure in the ISO-group. Blockade of the renin-angiotensin-
system (RAS) attenuated the observed changes indicating that the RAS may
be involved in the development of catecholamine-induced congestive heart
failure.
Mark J. Eisenberg, Eric J. Topol. Cleveland Clinic Foundation, Cleveland, OH
Background: Routine coronary stent placement after percutaneous translu-
minal coronary angioplasty (PTCA) reduces restenosis rates and the need for
revascularization of the target lesion during 6 months of follow-up. However,
the marginal costs associated with routine placement of coronary stents
is not known. Methods: Marginal costs associated with stent placement
(cost/clinical event avoided) were estimated using median costs for PTCA
($8,3001, stents ($1,600) and hospital days ($350/day) at the Cleveland Clinic.
Rates for coronary events, revascularization, angina, and restenosis were
obtained from data from the STRESS trial. Results: Routine coronary stent
placement increased in-hospital cost by >30% and was associated with high
marginal costs (Table).
Outcome % Reduction Marginal Cost
Coronary Event 4.3 $62,000
Revascularization 5.2 $51,000
Angina 7.8 $34,000
Restenosis 10.5 $25,000
Because these figures do not capture costs for bleeding and vascular com-
plications, follow-up clinic visits, and additional laboratory examinations, they
reflect conservative estimates of marginal costs. Conclusion: Although rou-
tine placement of coronary stents after PTCA appears to be clinically effica-
cious, this practice is associated with high marginal costs.
1 1032-1171 Systems Approach to Cardiac Surgery Delivery
Marc R. Pritzker, Mark Dixon, Richard Nelson, Frazier Eales, Carol Huttner,
Karen DuBois, Robert Emery. Minneapolis Heart Institute, Minneapolis, MN
The effect of a systems analysis approach (continuous quality improvement)
has been only infrequently reported for changing clinical care. Beginning in
1988 multidisciplinary provider groups sought to analyze resource consump-
tion, practice patterns; outcomes and variance associated with the provision
of care for DRGs 106 and 107 in a tertiary care setting. Based upon this, prac-
tice pattern initiatives were created for same day extubation, first day inten-
sive care unit (ICU) transfer, standardization of orders, and six post-operative
day length of stay. Programs were introduced through multidisciplinary edu-
cational programs, individual data feedback, and order revision. The impact
of this program can be seen.
